PEDIATRIC BLOOD & CANCER, cilt.58, sa.3, ss.453-458, 2012 (SCI-Expanded)
Background The aim was to evaluate the feasibility of donor lymphocyte infusion (DLI) in transplanted patients with thalassemia who were at imminent risk of graft rejection (GR).